AAAAAA

   
Results: 1-12 |
Results: 12
Orally active cephalosporins. Part 3: Synthesis, structure-activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporins
Authors: Yamamoto, H Terasawa, T Nakamura, A Kawabata, K Takasugi, H Tanaka, H Matsumoto, S Matsumoto, Y Tawara, S
Citation: H. Yamamoto et al., Orally active cephalosporins. Part 3: Synthesis, structure-activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporins, BIO MED CH, 9(2), 2001, pp. 465-475
Studies on anti-Helicobacter pylori agents. Part 2: New cephem derivatives
Authors: Yoshida, Y Matsuda, K Sasaki, H Matsumoto, Y Matsumoto, S Tawara, S Takasugi, H
Citation: Y. Yoshida et al., Studies on anti-Helicobacter pylori agents. Part 2: New cephem derivatives, BIO MED CH, 8(9), 2000, pp. 2317-2335
Network architecture technology for a highly versatile and economical optical access network
Authors: Sato, K Takasugi, H
Citation: K. Sato et H. Takasugi, Network architecture technology for a highly versatile and economical optical access network, NTT REVIEW, 12(2), 2000, pp. 85-89
In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi
Authors: Tawara, S Ikeda, F Maki, K Morishita, Y Otomo, K Teratani, N Goto, T Tomishima, M Ohki, H Yamada, A Kawabata, K Takasugi, H Sakane, K Tanaka, H Matsumo, F Kuwahara, S
Citation: S. Tawara et al., In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi, ANTIM AG CH, 44(1), 2000, pp. 57-62
Anti-Helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives
Authors: Katsura, Y Tomishi, T Inoue, Y Sakane, K Matsumoto, Y Morinaga, C Ishikawa, H Takasugi, H
Citation: Y. Katsura et al., Anti-Helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives, J MED CHEM, 43(17), 2000, pp. 3315-3321
FR192752, a novel orally active cephalosporin synthesis and biological properties
Authors: Yamamoto, H Kawabata, K Tawara, S Takasugi, H Tanaka, H
Citation: H. Yamamoto et al., FR192752, a novel orally active cephalosporin synthesis and biological properties, J ANTIBIOT, 53(10), 2000, pp. 1223-1227
Studies on anti-Helicobacter pylori agents. Part 1: Benzyloxyisoquinoline derivatives
Authors: Yoshida, Y Barrett, D Azami, H Morinaga, C Matsumoto, S Matsumoto, Y Takasugi, H
Citation: Y. Yoshida et al., Studies on anti-Helicobacter pylori agents. Part 1: Benzyloxyisoquinoline derivatives, BIO MED CH, 7(11), 1999, pp. 2647-2666
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative
Authors: Yoshida, Y Matsuda, K Sasaki, H Matsumoto, Y Matsumoto, S Takasugi, H
Citation: Y. Yoshida et al., Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative, BIOORG MED, 9(21), 1999, pp. 3123-3126
Anti-helicobacter pylori agents. 3. 2-[(arylalkyl)guanidino]-4-furylthiazoles
Authors: Katsura, Y Nishino, S Ohno, M Sakane, K Matsumoto, Y Morinaga, C Ishikawa, H Takasugi, H
Citation: Y. Katsura et al., Anti-helicobacter pylori agents. 3. 2-[(arylalkyl)guanidino]-4-furylthiazoles, J MED CHEM, 42(15), 1999, pp. 2920-2926
In vitro antibacterial activity of FK041, a new orally active cephalosporin
Authors: Watanabe, Y Hatano, K Matsumoto, Y Tawara, S Yamamoto, H Kawabata, K Takasugi, H Matsumoto, F Kuwahara, S
Citation: Y. Watanabe et al., In vitro antibacterial activity of FK041, a new orally active cephalosporin, J ANTIBIOT, 52(7), 1999, pp. 649-659
FK463, a novel water-soluble echinocandin lipopeptide: Synthesis and antifungal activity
Authors: Tomishima, M Ohki, H Yamada, A Takasugi, H Maki, K Tawara, S Tanaka, H
Citation: M. Tomishima et al., FK463, a novel water-soluble echinocandin lipopeptide: Synthesis and antifungal activity, J ANTIBIOT, 52(7), 1999, pp. 674-676
FR145715, a novel histamine H-2 receptor antagonist, with specific anti-Helicobacter pylori activities
Authors: Ishikawa, H Ito, H Higaki, M Higaki, M Matsumoto, Y Kamimura, T Katsura, Y Tomishi, T Inoue, Y Takasugi, H Tomoi, M Krakowka, S Yoshida, K
Citation: H. Ishikawa et al., FR145715, a novel histamine H-2 receptor antagonist, with specific anti-Helicobacter pylori activities, EUR J PHARM, 378(3), 1999, pp. 299-310
Risultati: 1-12 |